Cancer Research AACR Legacy  Telomeres
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Anttila, S.
Right arrow Articles by Nurminen, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Anttila, S.
Right arrow Articles by Nurminen, T.
[Cancer Research 63, 8623-8628, December 15, 2003]
© 2003 American Association for Cancer Research


Regular Articles

Methylation of Cytochrome P4501A1 Promoter in the Lung Is Associated with Tobacco Smoking

Sisko Anttila1, Jukka Hakkola4, Päivi Tuominen1, Eivor Elovaara2, Kirsti Husgafvel-Pursiainen2, Antti Karjalainen3, Ari Hirvonen2 and Tuula Nurminen3

1 Departments of Occupational Medicine,
2 Toxicology, and
3 Epidemiology and Biostatistics, Finnish Institute of Occupational Health, Helsinki, and
4 Department of Pharmacology and Toxicology, University of Oulu, Oulu, Finland

Cytochrome P4501A1 (CYP1A1), which is involved in the metabolic activation of polycyclic aromatic hydrocarbon procarcinogens derived from tobacco smoke, is induced in the lung up to 100-fold because of tobacco smoking. Our aim was to study whether promoter methylation has any role in the smoking-associated expression of CYP1A1 in human lung. Methylation of CpG sites up to 1.4 kb upstream of CYP1A1 gene was studied first by sequencing. Because methylation was observed between nucleotides -1400 and -1000, a methylation-specific single-strand conformational polymorphism method was designed for the region between nucleotides -1411 and -1295 that contains five potential methylation sites, one of them at the xenobiotic responsive element core sequence. Single-strand conformational polymorphism was used on DNA from normal lung samples and peripheral WBCs of smokers and nonsmokers, and on human lung adenocarcinoma (A549) and bronchial epithelial (Beas-2B) cell lines. In lung tissue complete or partial methylation occurred in 33% of heavy smokers (>15 cigarettes/day, n = 30), 71% of light smokers (<=15 cigarettes/day or quitted 1–7 days earlier, n = 42), and in 98% of nonsmokers (never and ex-smokers, n = 49). Methylation was found to increase in 1–7 days after quitting smoking. In active smokers the lack of methylation in the studied region of CYP1A1 promoter was associated with a slightly higher pulmonary 7-ethoxyresorufin O-deethylase activity in the regression models allowing for the daily tobacco consumption and age. No association was observed in WBC between methylation and tobacco smoking. In lung-derived cell lines the methylation remained stable regardless of induction with benzo(a)pyrene, but a higher induction was observed in Beas-2B cells, which also had less methylation than A549 cells. The association of tobacco smoking with CYP1A1 methylation in the lung suggests that promoter methylation is involved in the regulation of CYP1A1 induction in vivo.




This article has been cited by other articles:


Home page
Cancer Res.Home page
E. M. Wolff, G. Liang, C. C. Cortez, Y. C. Tsai, J. E. Castelao, V. K. Cortessis, D. D. Tsao-Wei, S. Groshen, and P. A. Jones
RUNX3 Methylation Reveals that Bladder Tumors Are Older in Patients with a History of Smoking
Cancer Res., August 1, 2008; 68(15): 6208 - 6214.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. T. Okino, D. Pookot, L.-C. Li, H. Zhao, S. Urakami, H. Shiina, M. Igawa, and R. Dahiya
Epigenetic Inactivation of the Dioxin-Responsive Cytochrome P4501A1 Gene in Human Prostate Cancer.
Cancer Res., August 1, 2006; 66(15): 7420 - 7428.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
P. A. Tsuji and T. Walle
Inhibition of benzo[a]pyrene-activating enzymes and DNA binding in human bronchial epithelial BEAS-2B cells by methoxylated flavonoids
Carcinogenesis, August 1, 2006; 27(8): 1579 - 1585.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
X. Wen and T. Walle
Preferential induction of CYP1B1 by benzo[a]pyrene in human oral epithelial cells: impact on DNA adduct formation and prevention by polyphenols
Carcinogenesis, October 1, 2005; 26(10): 1774 - 1781.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
P. W. Laird
Cancer epigenetics
Hum. Mol. Genet., April 15, 2005; 14(suppl_1): R65 - R76.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
A. L. Russo, A. Thiagalingam, H. Pan, J. Califano, K.-h. Cheng, J. F. Ponte, D. Chinnappan, P. Nemani, D. Sidransky, and S. Thiagalingam
Differential DNA Hypermethylation of Critical Genes Mediates the Stage-Specific Tobacco Smoke-Induced Neoplastic Progression of Lung Cancer
Clin. Cancer Res., April 1, 2005; 11(7): 2466 - 2470.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2003 by the American Association for Cancer Research.